Cancer Conversations Podcast – Episode #2: The Truth About BRCA Testing and Genetic Risk

May 22, 2017

Huma Q. Rana, MD, gives a consultation.
Huma Rana, MD, gives a consultation.

Although only a small percentage of breast cancers are considered hereditary, genetic testing and cancer risk — specifically the BRCA1/2 genes — have made many headlines in recent years. But what exactly does it mean to have a BRCA mutation, and what do women need to know?

In this Cancer Conversations podcast episode, Huma Rana, MD, clinical director of Dana-Farber’s Center for Cancer Genetics and Prevention, gives an overview of the link between genetics and women’s cancers, and why certain women have a higher risk for developing disease.

Listen to the podcast episode below or click “download” to listen later. Subscribe options are also available via iTunes, Google Play and RSS.

The Cancer Conversations series features Q&A-style conversations with Dana-Farber physicians, clinicians, and researchers. Topics include breast cancer research, precision cancer medicine, integrative therapies, cancer genetics, and more. Visit the Cancer Conversations page for more episodes.

Learn more about Dana-Farber’s Cancer Podcast Series.